Abstract: An exemplary system includes at least one valve configured to control fluid flow in a dual-clutch transmission system. A solenoid is operably connected to the at least one valve and configured to move the valve to a plurality of positions. A primary processing unit is in communication with the solenoid and configured to determine an intended position of the valve. A controller is configured to receive the intended position of the valve from the primary processing unit and generate a primary control signal associated with the intended position of the valve. The solenoid is configured to move the valve to the intended position based on the primary control signal. A secondary processing unit is configured to receive information from the primary processing unit and prevent the primary control signal from controlling the solenoid if the primary processing unit is unable to control the solenoid.

Abstract: A testing application may be executed on a mobile device associated with a mobile device build and may perform operations comprising: identifying a set of mobile applications designated for testing the mobile device build; for each mobile application in the set of mobile applications: receiving an indication that a user has selected the mobile application for execution; identifying a set of tests associated with the mobile application; for each test in the set of tests: prompting the user to perform an action specified by the test using the mobile application; prompting the user for feedback regarding performance of the action by the mobile application; receiving the feedback from the user; and storing the feedback received from the user.

Abstract: In a television system in which at least program title information for programs which are to be transmitted in the future is transmitted in advance to form a channel guide listing, apparatus is provided for searching the listing for specific user-entered information, and upon successful conclusion to the search, the apparatus schedules the tuning of the desired program, or in the alternative, notifies the viewer of the availability of the program. In those instances where descriptive text accompanies the program listing, apparatus of the invention performs a search of the text for a particular text string which may relate to the title, the star, the director, or the context of the program, among other search criteria.

Abstract: Compounds of formula (I) Q-L-W—C(?X)—Z—P wherein Q is an amine of the formula —N(R1)(R2); L is an alkyl or heterocyclyl-alkyl linker; W is a 6- or 7-membered aliphatic ring comprising ring atoms Y1 and Y2 which are linked to groups L and C(X) respectively and Y1 and Y2 are independently selected from N and C; X is O, N, N—CN or S; Z is NR3; P is an optionally substituted monocyclic or bicyclic aryl or heteroaryl group; and pharmaceutically acceptable salts or solvates thereof, are useful in the treatment of C—C chemokine mediated conditions.

Abstract: In a television system in which at least program title information for programs which are to be transmitted in the future is transmitted in advance to form a channel guide listing, apparatus is provided for searching the listing for specific user-entered information, and upon successful conclusion to the search, the apparatus schedules the tuning of the desired program, or in the alternative, notifies the viewer of the availability of the program. In those instances where descriptive text accompanies the program listing, apparatus of the invention performs a search of the text for a particular text string which may relate to the title, the star, the director, or the context of the program, among other search criteria.

Abstract: An air ammonia heater and vaporization chamber system utilizing a contiguous vaporization chamber having an inlet for receiving dilution air, which is passed across at least one heating element integrated into the vaporization chamber to heat and pre-heat the vaporization chamber. Aqueous or anhydrous ammonia is injected from at least one ammonia injector, which is integrated into the vaporization chamber, into the heated dilution air. The heated ammonia/air mixture may then be passed through a bed of packing prior to being released from the vaporization chamber. The bed of packing maintains the heated, homogenous ammonia/air mixture at a minimum temperature of 350° F. to ensure the air/ammonia mixture does not condense. The air ammonia heater and vaporization chamber system may be used in the vaporization and bleeding of ammonia with air for NOx reduction in the flue gas from heat recovery steam generation systems, packaged boilers, simple cycle catalyst systems or fired heaters.

Abstract: An ammonia injection grid for a selective catalytic reduction (SCR) system that provides uniform distribution of ammonia to the SCR catalyst in NOx reduction systems for heat recovery steam generation systems, packaged boilers, simple cycle catalyst systems and fired heaters for superior operational efficiency. The ammonia injection grid includes an injection tube having at least one nozzle for injecting ammonia into a flow of flue gas. The ammonia injection grid also includes a corrugated turbulence enhancer associated with the injection tube to generate turbulent wake to enhance turbulent mixing.

Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: Compounds of formula (I) Q-L-W—C(?X)—Z—P wherein Q is an amine of the formula —N(R1)(R2); L is an alkyl or heterocyclyl-alkyl linker; W is a 6- or 7-membered aliphatic ring comprising ring atoms Y1 and Y2 which are linked to groups L and C(X) respectively and Y1 and Y2 are independently selected from N and C; X is O, N, N—CN or S; Z is NR3; P is an optionally substituted monocyclic or bicyclic aryl or heteroaryl group; and pharmaceutically acceptable salts or solvates thereof, are useful in the treatment of C—C chemokine mediated conditions.

Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, n and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: A compound of formula (I) P—W—C(?X)-L-Q??(I) wherein P is an optionally substituted aryl or heteroaryl group; W is an optionally substituted 6 or 7-membered aliphatic ring comprising ring atoms Y1 and Y2 independently selected from Oxygen and Nitrogen, X is selected from Oxygen, Nitrogen and Sulphur; L is an optional C1-4 linker; and Q is an optionally substituted 4-7 membered aliphatic ring: for use in the treatment of chemokine mediated diseases or disorders.

Abstract: Compounds of formula (I) Q-L-W—C(?X)—Z—P wherein Q is an amine of the formula —N(R1)(R2); L is an alkyl or heterocyclyl-alkyl linker; W is a 6- or 7-membered aliphatic ring comprising ring atoms Y1 and Y2 which are linked to groups L and C(X) respectively and Y1 and Y2 are independently selected from N and C; X is O, N, N—CN or S; Z is NR3; P is an optionally substituted monocyclic or bicyclic aryl or heteroaryl group; and pharmaceutically acceptable salts or solvates thereof, are useful in the treatment of C-C chemokine mediated conditions.

Abstract: Embodiments are described in terms of selective methods of sealing separators and jellyroll electrode assemblies and cells made using such methods. More particularly, methods of selectively heat sealing separators to encapsulate one of two electrodes for nickel-zinc rechargeable cells having jellyroll assemblies are described. Selective heat sealing may be applied to both ends of a jellyroll electrode assembly in order to selectively seal one of two electrodes on each end of the jellyroll.

Abstract: A method of making a polyurethane foam from a mixture of isocyanate modified polyol and foam-forming ingredients, wherein the isocyanate modified polyol is made by reacting at least one polyol with at least one multifunctional isocyanate, wherein the isocyanate modified polyol is a non-foamed polyol polymer having available OH groups, wherein the foam forming ingredients comprise at least a multifunctional isocyanate and a foaming agent, preferably water, and characterised in that (i) the at least one polyol from which the isocyanate modified polyol is made comprises at least one lipid-based polyol which has undergone reaction with the isocyanate in the presence of a PU gelation catalyst, and/or (ii) the isocyanate modified polyol is mixed with a lipid-based polyol prior to, or at the same time as, foaming.

Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, R4, R5 and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: A multi-bed selective catalytic reduction system comprising a gas input duct, a first ammonia injection grid assembly located downstream from the gas input duct, a first selective catalytic reduction catalyst assembly located downstream from the first ammonia injection grid assembly, a second ammonia injection grid assembly located downstream from the first selective catalytic reduction catalyst assembly, a second selective catalytic reduction catalyst assembly located downstream from the second ammonia injection grid assembly, and an exhaust stack located downstream from the second selective catalytic reduction catalyst assembly.

Abstract: The invention relates to thiophene carboxamides of formula (I), wherein Ar, R1, R2, R3, R4, R5, m and n are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention relates to thiophene carboxamides of formula (I), wherein A, R1, R2, R3, R4, R5 and X are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention relates to thiophene carboxamides of formula (I) wherein Ar, R1, R2, R3, R4, R5, m and n are as defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The present invention provides a buckle and tongue combination for restraining an occupant in a seat, the buckle and tongue combination.